These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23932721)

  • 1. Indenoisoquinoline derivatives as topoisomerase I inhibitors that suppress angiogenesis by affecting the HIF signaling pathway.
    Xu X; Liu F; Zhang S; Jia J; Li Z; Guo X; Yang Y; Sun H; You Q
    Biomed Pharmacother; 2013 Oct; 67(8):715-22. PubMed ID: 23932721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
    Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrrolo[2,3-α]carbazole derivatives as topoisomerase I inhibitors that affect viability of glioma and endothelial cells in vitro and angiogenesis in vivo.
    Lampropoulou E; Manioudaki M; Fousteris M; Koutsourea A; Nikolaropoulos S; Papadimitriou E
    Biomed Pharmacother; 2011 Jun; 65(3):142-50. PubMed ID: 21616631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway.
    Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC
    J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the hypoxia-inducible factor signaling pathway as a therapeutic modality to regulate retinal angiogenesis.
    DeNiro M; Alsmadi O; Al-Mohanna F
    Exp Eye Res; 2009 Nov; 89(5):700-17. PubMed ID: 19580810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of indatraline on angiogenesis suppression through HIF-1α-mediated VEGF inhibition.
    Yen CN; Cho YS; Kwon HJ
    Biochem Biophys Res Commun; 2017 Apr; 485(2):349-354. PubMed ID: 28216154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.
    Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferulic acid augments angiogenesis via VEGF, PDGF and HIF-1 alpha.
    Lin CM; Chiu JH; Wu IH; Wang BW; Pan CM; Chen YH
    J Nutr Biochem; 2010 Jul; 21(7):627-33. PubMed ID: 19443196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxypodophyllotoxin exerts both anti-angiogenic and vascular disrupting effects.
    Jiang Z; Wu M; Miao J; Duan H; Zhang S; Chen M; Sun L; Wang Y; Zhang X; Zhu X; Zhang L
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1710-9. PubMed ID: 23702033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of nicotinamide derivative as anti-angiogenic agents.
    Choi HE; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2083-8. PubMed ID: 23453071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sphingosine-1-phosphate derivative NHOBTD inhibits angiogenesis both in vitro and in vivo.
    Kim BS; Park H; Ko SH; Lee WK; Kwon HJ
    Biochem Biophys Res Commun; 2011 Sep; 413(2):189-93. PubMed ID: 21888894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic effect of furanodiene on HUVECs in vitro and on zebrafish in vivo.
    Zhong ZF; Hoi PM; Wu GS; Xu ZT; Tan W; Chen XP; Cui L; Wu T; Wang YT
    J Ethnopharmacol; 2012 Jun; 141(2):721-7. PubMed ID: 21911050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new anti-angiogenic small molecule, G0811, inhibits angiogenesis via targeting hypoxia inducible factor (HIF)-1α signal transduction.
    Kim KH; Jung HJ; Kwon HJ
    Biochem Biophys Res Commun; 2013 Nov; 441(2):399-404. PubMed ID: 24161739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of new fluorinated and chlorinated indenoisoquinoline topoisomerase I poisons.
    Beck DE; Lv W; Abdelmalak M; Plescia CB; Agama K; Marchand C; Pommier Y; Cushman M
    Bioorg Med Chem; 2016 Apr; 24(7):1469-79. PubMed ID: 26906474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New inhibitors of angiogenesis with antitumor activity in vivo.
    Marín-Ramos NI; Alonso D; Ortega-Gutiérrez S; Ortega-Nogales FJ; Balabasquer M; Vázquez-Villa H; Andradas C; Blasco-Benito S; Pérez-Gómez E; Canales Á; Jiménez-Barbero J; Marquina A; del Prado JM; Sánchez C; Martín-Fontecha M; López-Rodríguez ML
    J Med Chem; 2015 May; 58(9):3757-66. PubMed ID: 25906180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and practical antiangiogenic agents inspired by cortistatin A.
    Czakó B; Kürti L; Mammoto A; Ingber DE; Corey EJ
    J Am Chem Soc; 2009 Jul; 131(25):9014-9. PubMed ID: 19469509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RY10-4, a novel anti-tumor compound, exhibited its anti-angiogenesis activity by down-regulation of the HIF-1α and inhibition phosphorylation of AKT and mTOR.
    Liu Z; Yuan Q; Zhang X; Xiong C; Xue P; Ruan J
    Cancer Chemother Pharmacol; 2012 Jun; 69(6):1633-40. PubMed ID: 22565593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.